Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • B. Riley Securities cut Ciena Corporation CIEN price target from $97 to $89. B. Riley Securities analyst Dave Kang maintained a Buy rating. Ciena shares closed at $63.95 on Tuesday. See how other analysts view this stock.
  • Truist Securities boosted the price target for Expedia Group, Inc. EXPE from $163 to $175. Truist Securities analyst Greg Miller maintained a Hold rating. Expedia shares closed at $163.75 on Tuesday. See how other analysts view this stock.
  • JP Morgan cut Tesla, Inc. TSLA price target from $135 to $120. JP Morgan analyst Ryan Brinkman maintained an Underweight rating. Tesla shares closed at $230.58 on Tuesday. See how other analysts view this stock.
  • Raymond James slashed the price target for Diamondback Energy, Inc. FANG from $245 to $214. Raymond James analyst John Freeman maintained a Strong Buy rating. Diamondback Energy shares closed at $144.65 on Tuesday. See how other analysts view this stock.
  • DA Davidson cut the price target for RumbleOn, Inc. RMBL from $5 to $4. DA Davidson analyst Michael Baker maintained a Neutral rating. RumbleOn shares closed at $3.59 on Tuesday. See how other analysts view this stock.
  • Susquehanna cut Teradyne, Inc. TER price target from $165 to $155. Susquehanna analyst Mehdi Hosseini maintained a Positive rating. Teradyne shares settled at $87.07 on Tuesday. See how other analysts view this stock.
  • RBC Capital slashed Illumina, Inc. ILMN price target from $247 to $128. RBC Capital analyst Conor McNamara maintained an Outperform rating. Illumina shares closed at $84.52 on Tuesday. See how other analysts view this stock.
  • Macquarie cut Vail Resorts, Inc. MTN price target from $195 to $185. Macquarie analyst Paul Golding maintained a Neutral rating. Vail Resorts shares closed at $165.42 on Tuesday.  See how other analysts view this stock.
  • Wedbush cut the price target for Arvinas, Inc. ARVN from $57 to $12. Wedbush analyst Robert Driscoll downgraded the stock from Outperform to Neutral. Arvinas shares settled at $8.30 on Tuesday. See how other analysts view this stock.
  • Citigroup raised Core Laboratories Inc. CLB price target from $15 to $16. Citigroup analyst Scott Gruber upgraded the stock from Sell to Neutral. Core Laboratories shares closed at $14.62 on Tuesday. See how other analysts view this stock.

Read This Next:

Got Questions? Ask
Which analysts are bullish on Ciena Corporation?
How might Expedia Group benefit from travel trends?
What factors could drive Tesla's price down further?
Which energy stocks could thrive with Diamondback Energy's rating change?
What are the implications for RumbleOn after its price cut?
How will Teradyne perform against its lowered target?
Which biotech companies could be impacted by Illumina's downgrade?
What other tourism stocks might follow Vail Resorts in price adjustments?
How will Arvinas affect investor sentiment in biotech?
Could Core Laboratories see increased interest from investors?
Market News and Data brought to you by Benzinga APIs

Posted In: